Bonnie van Wilgenburg

Bonnie van Wilgenburg is a Principal at Monograph.
Prior to joining Monograph, Bonnie worked for four years at a leading European venture capital firm, Forbion, where her activities included sourcing, evaluation, deal execution and portfolio management of life science companies.
She was a board observer at Inflazome, which was sold to Roche in 2020 for US$450 million plus milestone payments.
Before that she worked for a decade as an academic scientist in the fields of immunology, virology and stem cells at Oxford University and the University of Melbourne.
She earned her DPhil at Oxford.